URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS-ASSOCIATED LIVER-DISEASE - FINAL REPORT OF A MULTICENTER TRIAL

被引：9
|
作者：
COLOMBO, C
PODDA, M
BATTEZZATI, PM
SANTINI, B
IAPICHINO, L
QUATTRUCCI, S
LUCIDI, V
FERRARI, R
SCOTTA, S
MINICUCCI, L
CANDUSSO, M
VALLETTA, E
GAGLIARDINI, R
SANTAMARIA, F
BATTISTINI, F
GIUNTA, A
机构：
[1] CYST FIBROSIS CTR,MILAN,ITALY
[2] CYST FIBROSIS CTR,TURIN,ITALY
[3] CYST FIBROSIS CTR,PALERMO,ITALY
[4] CYST FIBROSIS CTR,ROME,ITALY
[5] CYST FIBROSIS CTR,FLORENCE,ITALY
[6] CYST FIBROSIS CTR,GENOA,ITALY
[7] CYST FIBROSIS CTR,TRIESTE,ITALY
[8] CYST FIBROSIS CTR,VERONA,ITALY
[9] CYST FIBROSIS CTR,ANCONA,ITALY
[10] CYST FIBROSIS CTR,CESENA,ITALY
[11] CYST FIBROSIS CTR,NAPLES,ITALY
[12] CYST FIBROSIS CTR,PAVIA,ITALY
来源：
HEPATOLOGY | 1993年 / 18卷 / 04期
关键词：
D O I：
10.1016/0270-9139(93)92096-I
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [31] HEPATOBILIARY SCANNING IN PATIENTS WITH CYSTIC-FIBROSIS AND LIVER-DISEASE BEFORE AND AFTER URSODEOXYCHOLIC ACID (UDCA) THERAPY
    COLOMBO, C
    CASTELLANI, MR
    SEREGNI, E
    APOSTOLO, MG
    FORMAN, S
    GIUNTA, A
    PEDIATRIC RESEARCH, 1990, 27 (05) : 536 - 536
  • [32] SCINTIGRAPHIC DOCUMENTATION OF AN IMPROVEMENT IN HEPATOBILIARY EXCRETORY FUNCTION AFTER TREATMENT WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CYSTIC-FIBROSIS AND ASSOCIATED LIVER-DISEASE
    COLOMBO, C
    CASTELLANI, MR
    BALISTRERI, WF
    SEREGNI, E
    ASSAISSO, ML
    GIUNTA, A
    HEPATOLOGY, 1992, 15 (04) : 677 - 684
  • [33] Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis
    Smith, JL
    Lewindon, PJ
    Hoskins, AC
    Pereira, TN
    Setchell, KDR
    O'Connell, NC
    Shepherd, RW
    Ramm, GA
    HEPATOLOGY, 2004, 39 (06) : 1673 - 1682
  • [34] Ursodeoxycholic Acid for Cystic Fibrosis Related Liver Disease, Our Experience
    G Mujtaba
    P Greally
    B Elnazir
    Pediatric Research, 2011, 70 : 534 - 534
  • [35] URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS RELATED LIVER DISEASE, OUR EXPERIENCE
    Mujtaba, G.
    Greally, P.
    Elnazir, B.
    PEDIATRIC RESEARCH, 2011, 70 : 534 - 534
  • [36] Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease
    Siano, Maria
    De Gregorio, Fabiola
    Boggia, Bartolo
    Sepe, Angela
    Ferri, Pasqualina
    Buonpensiero, Paolo
    Di Pasqua, Antonio
    Raia, Valeria
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (06) : 428 - 431
  • [37] Ursodeoxycholic acid for cystic fibrosis-related liver disease (Review)
    Cheng, Katharine
    Ashby, Deborah
    Smyth, Rosalind L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [38] Noncirrhotic Presinusoidal Portal Hypertension Is Common in Cystic Fibrosis-Associated Liver Disease
    Wittes, Peter
    Libbrecht, Louis
    Roskams, Tania
    De Boeck, Kris
    Dupont, Lieven
    Proesmans, Marijke
    Vermeulen, Francois
    Strandvik, Birgitta
    Lindblad, Anders
    Stephenne, Xavier
    Sokal, Etienne
    Gosseye, Serge
    Heye, Sam
    Maleux, Geert
    Aerts, Raymond
    Monbaliu, Diethard
    Pirenne, Jacques
    Hoffman, Ilse
    Nevens, Frederik
    Cassiman, David
    HEPATOLOGY, 2011, 53 (03) : 1064 - 1065
  • [39] A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease
    Freeman, A. Jay
    Sellers, Zachary M.
    Mazariegos, George
    Kelly, Andrea
    Saiman, Lisa
    Mallory, George
    Ling, Simon C.
    Narkewicz, Michael R.
    Leung, Daniel H.
    LIVER TRANSPLANTATION, 2019, 25 (04) : 640 - 657
  • [40] Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease
    Debray, Dominique
    Kelly, Deirdre
    Houwen, Roderick
    Strandvik, Birgitta
    Colombo, Carla
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 : S29 - S36
12345